Welcome to our dedicated page for CANNABIS GLOBAL news (Ticker: CBGL), a resource for investors and traders seeking the latest updates and insights on CANNABIS GLOBAL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CANNABIS GLOBAL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CANNABIS GLOBAL's position in the market.
Cannabis Global, Inc. (OTC PINK:CBGL) and Marijuana Company of America (OTC PINK:MCOA) have announced the funding of a new cannabis extract laboratory in Lynwood, California. This facility, managed by Cannabis Global's subsidiary, Natural Plant Extract, is set to produce a crystalline THC-A product known as 'Diamonds'. Aiming to capitalize on the growing demand for potent cannabis products, the laboratory will enhance both companies' revenue streams and market presence. The cannabis concentrate market has seen over 40% growth, making this investment timely.
Cannabis Global (OTC PINK:CBGL) and Marijuana Company of America (OTC PINK:MCOA) announced the closure of a joint venture to establish a manufacturing and research facility for cannabis concentrates and cannabinoid polymeric nanoparticles in Lynwood, California. This venture, named MCOA Lynwood Services, Inc., will focus on producing cannabis concentrates for the California market and advancing Cannabis Global's patented technologies. Cannabis Global will hold a 60% stake, allowing consolidation of revenues, while MCOA will contribute capital and equipment for production.
Cannabis Global, Inc. (OTC PINK:CBGL) and Marijuana Company of America (OTC PINK:MCOA) announced plans to create a cannabis laboratory in Lynwood, CA. Under a letter of intent, MCOA will invest $250,000, with $135,000 allocated for equipment. The lab, managed by Natural Plant Extract of California (NPE), focuses on volatile extraction for market sale. Cannabis Global aims to reduce costs and enter the cannabis concentrate market. Both companies will negotiate profit-sharing terms. The venture leverages NPE's Type 7 permit, which is stringent in California.
Cannabis Global, Inc. (OTC PINK:CBGL) announced significant financial growth, reporting $11.9 million in assets, a 275% increase from the previous quarter, and equity growth of 397% to $4.3 million. This surge is primarily attributed to gaining a controlling 56.5% stake in Natural Plant Extract of California. The company anticipates substantial revenue growth with new cannabis product launches expected to capitalize on the expanding California cannabis market, projected to grow from $4.4 billion in 2020 to over $7 billion by 2022.
Cannabis Global, Inc. (OTC PINK:CBGL) has announced the start of production for its Northern Lights branded cannabis products at its newly acquired facility in Lynwood, California, beginning April 1st. The company holds a 56.4% controlling interest in Natural Plant Extract (NPE), which specializes in cannabis manufacturing and distribution. The facility is equipped with a Type 7 license, allowing for versatile cannabinoid extraction, and features tax advantages that enhance profit margins. Cannabis Global plans to leverage this operation for product development and research on innovative cannabis technologies.
Cannabis Global (CBGL) announced its cannabis product manufacturing initiative at its Lynwood, California facility, Natural Plant Extract (NPE). With a 56.4% ownership in NPE, the company aims to ramp up production of cannabis edibles and flower-based products. The Lynwood site, with Type 7 licensing, offers competitive advantages such as low city tax rates. This initiative is expected to significantly boost revenue. The company is also leveraging synergies with its distribution operations and developing secure transport technologies.
Cannabis Global, Inc. (CBGL) has announced its entry into the cannabis edibles market through its majority-owned subsidiary, Natural Plant Extract of California Inc. (NPE). The company acquired 56.5% of NPE's shares, which holds necessary licenses for manufacturing and distribution in California. They plan to produce unique cannabis edibles leveraging proprietary technologies, specifically focusing on a high melt product line. The Northern Lights brand will target both mass and premium markets, with production expected to begin in Q2 2021. This strategic move positions CBGL to capitalize on the growing cannabis edibles sector.
Cannabis Global Inc. (CBGL) has announced an interview featuring CEO Arman Tabatabaei, discussing the company's recent acquisition of Natural Plant Extract (NPE) and its potential benefits. The company has increased ownership in NPE, which holds a crucial Type 7 license for cannabis extraction and distribution in California. Tabatabaei emphasizes plans for expansion in anticipation of federal legalization of cannabis, aiming for multi-state operator status. With six provisional patents and three non-provisional patents filed, CBGL aims to leverage its technology nationally, enhancing profit margins.
Cannabis Global, Inc. (OTC PINK:CBGL) has acquired a 56.4% controlling stake in Natural Plant Extract (NPE), a licensed cannabis manufacturer and distributor in California. This acquisition, which closed on February 16, 2021, will allow Cannabis Global to consolidate NPE’s financials and fully utilize its Type 7 manufacturing license. The Company aims to leverage NPE's operations to expand into multi-state operations after expected federal regulatory changes, tapping into strong synergistic opportunities with its proprietary technologies.
Cannabis Global, Inc. (OTC PINK:CBGL) is strategically positioning itself within the expanding national and regional cannabis markets. CEO Arman Tabatabaei highlighted the company's focus on the California market, the largest in the U.S., while aiming for national expansion. Key initiatives include the Comply Bag™ for secure cannabis transport, increased ownership in Natural Plant Extract to 37.6%, and a significant stake in Marijuana Company of America valued at approximately $16.9 million. The company is also developing cannabis infusion technologies, underscoring its growth potential.
FAQ
What is the current stock price of CANNABIS GLOBAL (CBGL)?